(Q41116524)

27 September 2017

Use of plasma levels in evaluation of procainamide dosage (English)

1 reference

27 September 2017

Shaw TR

1

1 reference

27 September 2017

Kumana CR

2

1 reference

27 September 2017

Royds RB

3

1 reference

27 September 2017

Padgham CM

4

1 reference

27 September 2017

Hamer J

5

1 reference

27 September 2017

1 March 1974

1 reference

27 September 2017

British Heart Journal

1 reference

27 September 2017

36

1 reference

27 September 2017

3

1 reference

27 September 2017

265-270

1 reference

Antiarrhythmic Prophylaxis with Procainamide in Acute Myocardial Infarction

27 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=458828

Long-term use of procaine amide following acute myocardial infarction

14 June 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=458828

Arrhythmias and late sudden death after myocardial infarction

14 June 2018

1 reference

12 December 2020

Hospital Mortality in Acute Myocardial Infarction

1 reference

12 December 2020

Drug therapy. Serum drug concentrations as therapeutic guides

1 reference

12 December 2020

Intermittent intravenous procaine amide to treat ventricular arrhythmias. Correlation of plasma concentration with effect on arrhythmia, electrocardiogram, and blood pressure

1 reference

12 December 2020

Identifiers

DOI

10.1136/HRT.36.3.265

1 reference

27 September 2017

1 reference

27 September 2017

PubMed publication ID

4132893

1 reference